SCHEMBL19880534

SCHEMBL19880534

NC(=O)c1cc(F)cc(S)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 5/20 0.50
▸ CES2 O00748 3/20 0.44
▸ CES1 P23141 3/20 0.44
▸ HCAR1 Q9BXC0 1/20 0.38
▸ CYP3A4 P08684 2/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ TSHR P16473 2/20 0.34
▸ POLB P06746 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ RECQL P46063 1/20 0.34
▸ BLM P54132 1/20 0.34
▸ PMP22 Q01453 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ PTPN11 Q06124 1/20 0.34
▸ HPGDS O60760 1/20 0.33
▸ MAOB P27338 2/20 0.33
▸ PARP10 Q53GL7 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7077548 0.84 PARP1 (0.60) PARP1CES2CES1HCAR1CYP3A4
SCHEMBL5384227 0.84 CYP3A4 (0.43) PARP1CYP3A4SMN1; SMN2TSHRPOLB
SCHEMBL259315 0.84 CES2 (0.62) PARP1CES2CES1HCAR1CYP3A4
SCHEMBL11820909 0.80 HCAR1 (0.59) CES2CES1HCAR1SMN1; SMN2TSHR
Thiourea SCHEMBL28876257 0.77 CES2 (0.54) PARP1CES2CES1HCAR1CYP3A4
SCHEMBL31196365 0.76 HCAR1 (0.65) PARP1CES2CES1HCAR1CYP3A4
SCHEMBL21516794 0.76 PARP1 (0.52) PARP1CES2CES1HCAR1CYP3A4
SCHEMBL3090976 0.76 PARP1 (0.52) PARP1CES2CES1HCAR1CYP3A4
SCHEMBL27940624 0.76 HCAR1 (0.59) PARP1CES2CES1HCAR1CYP3A4
SCHEMBL6093189 0.76 CYP3A4 (0.38) PARP1CYP3A4SMN1; SMN2TSHRPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9896432-B2 Somatostatin modulators and uses thereof Crinetics Pharmaceuticals, Inc. (US) 2018-02-20 — — US disclosed
Send feedback